This contribution reviews briefly the history of the discovery and characterization of peptic activity; secretory models and current concepts regarding the regulation of pepsinogen secretion; and evidence that pepsin is a necessary co-factor for gastroduodenal mucosal injury. Several animal studies indicate that peptic activity is required for acid-and nonsteroidal anti-inflammatory druginduced gastroduodenal ulceration. A more vigorous approach to the development of anti-peptic drugs for the treatment of peptic ulcer disease is encouraged.
INTRODUCTION
The contribution of pepsin to the pathogenesis of gastroduodenal mucosal damage is implicit in the term "peptic" ulcer disease. Nonetheless, for many years continuing into the present era, elucidation of the physiology and pathophysiology of pepsinogen secretion has taken a back seat to the study of gastric acid secretion. Likewise, medical therapy of gastrointestinal mucosal damage has focused on agents that neutralize or inhibit the secretion of gastric acid. This, despite the importance of gastric acid in preventing infection and promoting the absorption of various nutrients. Surprisingly, little effort has been directed to develop therapies that might inactivate pepsin or prevent the secretion of pepsinogen, maneuvers that are less likely to disrupt gastric homeostasis and result in bacterial overgrowth, gastrin hypersecretion and other side-effects of acid suppression therapy.
In this paper, the author will review briefly the history of the discovery and characterization of peptic activity; secretory models and current concepts regarding the regulation of pepsinogen secretion; and evidence that pepsin is a necessary co-factor in the development of gastroduodenal mucosal damage. THE [2] . Subsequent investigations from the laboratories of Wasmann, and particularly Langley during the late 1800s, resulted in the discovery that pepsin is secreted as a proenzyme, designated pepsinogen [3] [4] [5] . Pepsin (mol. wt., 35.5 kDa) and pepsinogen (mol. wt., 42.5 kDa) were crystallized by Northrop [6] and Herriott [7] , respectively.
Herriot established that at acidic pH (< 6.0) pepsinogen undergoes autocatalysis whereby a 3.1-kDa inhibitory piece is cleaved from the N-terminal portion of the molecule and digested by the resulting pepsin as the pH drops below 4.0 [8] . The pH optimum for pepsin, depending on the substrate, ranges between 1.0 and 3.0 [9, 10] . Commonly, peptic activity is determined by examining the acid hydrolysis of native or radiolabeled hemoglobin or albumin (measuring the release into the medium of tyrosine or radiolabel, respectively).
PHYSIOLOGICAL MODELS USED TO STUDY PEPSINOGEN SECRETION
As in Beaumont's experiments, models examining secretion in intact, innervated tomachs provide the most physiological approximation of pepsinogen secretion in iumans and other species. Nevertheless, because gastric juice is comprised of components secreted by a variety of cells, dissecting the relative contribution of neural and hormonal stimuli to the control of pepsinogen secretion may be quite difficult. "Wash-out" of preformed pepsinogen from gastric glands along with fluid and electrolytes may result in overestimation of secretion. Hence, investigators have developed peptic models, like mucosal cell cultures, gastric glands and dispersed chief cells, which obviate some of these difficulties. The major disadvantage of these models, including the use of dispersed peptic cells from human stomach [11] , is that physiological cell-cell interactions may be lost.
REGULATION OF PEPSINOGEN SECRETION The following represents a brief description of the regulation of pepsinogen secretion. For a more detailed analysis of signal transduction pathways in gastric chief cells the reader may consult a recent review [12] .
In general, there are two major signal transduction pathways that mediate pepsinogen secretion (Figure 1) . In one pathway, the interaction of agents like cholecystokinin, gastrin and cholinergic agonists with specific cell membrane receptors results in the activation of phospholipase C, phospholipid turnover, and the production of inositol trisphosphate (Ip3)b and diacylglycerol (DAG). In turn, IP3 stimulates the release of calcium from intracellular stores thereby activating kinases, like calcium/calmodulin kinase-II [13] , and phosphatases, like protein phosphatase-2B (calcineurin) [14] . DAG directly activates different isoforms of protein kinase C [15] .
In the other pathway, the interaction of agents like vasoactive intestinal peptide, pituitary adenylyl cyclase activating peptide, secretin, glucagon-like peptide-1, prostaglandins Figure 1 . Cartoon illustrating cellular regulation of pepsinogen secretion from dispersed chief cells from guinea pig stomach. On left, colors indicate three sets of agents: those that activate phospholipase C and phospholipid turnover, those that activate adenylyl cyclase and cause a rise in cellular cAMP, and those that inhibit agonist-induced stimulation of adenylyl cyclase. Increases in cellular calcium, cAMP and DAG activate kinases and phosphatases that mediate pepsinogen secretion. Broken arrow indicates interaction between the phospholipase C and adenylyl cyclase pathways. Question mark indicates distal components of signalling pathways that remain to be elucidated. Gq, Gs, Gi = guanine nucleotide binding proteins; IP3 = inositol trisphosphate; DAG = diacylglycerol. and cholera toxin with specific cell-membrane receptors results in the activation of adenylyl cyclase and the production of cAMP. cAMP directly activates protein kinase A. Although some evidence exists that somatostatin, peptide YY and neuropeptide Y may negatively modulate adenylyl cyclase in dispersed chief cells, the physiological importance of this observation is not clear [16] [17] [18] .
Besides the initiation of cascades that result in activation of protein kinases and/or phosphatases, similarities between these signal transduction pathways include the involvement of heterotrimeric guanine nucleotide binding proteins, like Gq and Gs, in mediating the steps following ligand-receptor interaction. Moreover, there is evidence of interaction between the phospholipase C and adenylyl cyclase pathways, so-called "cross-talk," which results in augmentation of cellular levels of cAMP and potentiation of pepsinogen secretion (indicated by the broken arrow in Figure 1 ) [19, 20] .
The current focus of activity in our laboratory is identification and characterization of the substrates for activated chief cell kinases and phosphatases (note the question mark in Figure 1 ). For example, recent work indicates that agonist-induced increases in chief cell calcium concentration results in activation of protein phosphatase-2B and a consequent reduction in the phosphorylation of 18-and 55-kDa cytoskeletal proteins [14] . Nevertheless, it is apparent that factors such as an increase in the luminal concentration of hydrochloric acid, gastric mucosal ischemia and drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs), that break down the mucosal barrier predispose to ulceration. Many of these events are associated with a drop in intramucosal pH, which leads to activation of pepsinogen to pepsin, and approaches the pH optimum for this acid protease.
Several observations indicate that pepsin is a necessary co-factor for gastric mucosal ulceration. Early studies indicated that the addition of pepsin to acid perfusates of canine or feline stomach or intestine, respectively, increased the likelihood and severity of mucosal ulceration [21] [22] [23] . More recent studies indicate not only that pepsin potentiates acid injury to the gastrointestinal tract, but that, in the absence of pepsin, acid may be relatively innocuous. In rats, Alphin et al. [24] found that inhibition of peptic activity prevented gastric ulceration even when the pH of the perfusate was as low as 1.3. Ford et al. [25] demonstrated that acid proteinase activity in rat gastric mucosa increased following ischemia and that this was associated with mucosal erosion. Treatment with luminal inhibitors of peptic activity reduced tissue proteinase activity and the number of erosions [25] . Similar findings were observed by Joffe et al. [26] when rat duodena were perfused in the absence or presence of pepsin.
In a recent study, Gaw et 
